Novel drug delivery system using thermoreversible gelation polymer for malignant glioma

Journal of Neuro-Oncology

Volumn 77, Issue 1, 2006, Pages 9-15

  Arai, Takao ^a   Joki, Tatsuhiro ^a   Akiyama, Masaharu ^a   Agawa, Miyuki ^a   Mori, Yuichi ^b   Yoshioka, Hiroshi ^b   Abe, Toshiaki ^a  

^a JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b WASEDA UNIVERSITY   (Japan)

Author keywords

Doxorubicin; Local chemotherapy; Malignant glioma; Thermoreversible gelation polymer

Indexed keywords

DOXORUBICIN; KI 67 ANTIGEN; MACROGOL; METHACRYLIC ACID DERIVATIVE; POLY(N ISOPROPYLACRYLAMIDE); POLYMER; WATER;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN DETECTION; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; DISEASE MODEL; DRUG DELIVERY SYSTEM; DRUG DIFFUSION; DRUG EFFICACY; DRUG RELEASE; GELATION; GLIOBLASTOMA; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MALE; MOUSE; NONHUMAN; PHASE TRANSITION; RELIABILITY; SOLID; SOLUBILITY; TRANSITION TEMPERATURE;

ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; DIFFUSION; DOXORUBICIN; DRUG CARRIERS; DRUG IMPLANTS; GLIOMA; HUMANS; HYDROGELS; MALE; MICE; MICE, INBRED BALB C; MICE, NUDE; NEOPLASMS, EXPERIMENTAL; POLYETHYLENE GLYCOLS; POLYMERS; PROPYLENE GLYCOLS; SOLUBILITY; TEMPERATURE; TUMOR CELLS, CULTURED;

EID: 33745042061     PISSN: 0167594X     EISSN: 15737373     Source Type: Journal    
DOI: 10.1007/s11060-005-9001-4     Document Type: Article

References (34)

1. Cairncross JG, Macdonald DR, Ramsay DA Aggressive oligodendroglioma: A chemosensitive tumor Neurosurgery 31: 78-82, 1992
2. Fine HA, Dear KB, Loeffler JS, Black PM, Canellos GP Meta-analysis of radiation therapy with and without adjuvant chemotherapy for malignant gliomas in adults Cancer 71: 2585-2597, 1993
3. Hildebrand J, Dewitte O, Dietrich PY, de Tribolet N Management of malignant brain tumors Eur Neurol 38: 238-253, 1997
4. Lesser G.J, Grossman S The chemotherapy of high-grade astrocytomas Semin Oncol 21: 220-235, 1994
5. Shapiro WR, Green SB, Burger PC, Selker RG, VanGilder JC, Robertson JT, Mealey J Jr, Ransohff J, Mahaley MS Jr: A randomized comparison of intra-arterial versus intravenous BCNU, with or without intravenous 5-fluorouracil, for newly diagnosed patients with malignant glioma. J Neurosurg 76: 772-781, 1992
6. Walker MD, Green SB, Byar DP,Alexander E Jr, Batzdorf U, Brooks WH, Hunt WE, MacCarty CS, Mahaley MS Jr, Mealey J Jr, Owens G, Ransohoff J, 2nd, Robertson JT, Shapiro WR, Smith KR Jr, Wilson CB, Strike TA Randomized comparisons of radiotherapy and nitrosoureas for the treatment of malignant glioma after surgery N Engl J Med 303: 1323-1329, 1980
7. Hochberg FH, Pruitt A Assumptions in the radiotherapy of glioblastoma Neurology 30: 907-911, 1980
8. Stewart LA Chemotherapy in adult high-grade glioma: A systematic review and meta-analysis of individual patient data from 12 randomized trials Lancet 359: 1011-1018, 2002
9. Brem H, Brown M, Coleman RE, Friedman AH,Friedman HS, McLendon RE, Bigner SH, Zhao XG, Wikstrand CJ, Pegram CN Placebo-controlled trial of safety and efficacy of intraoperative controlled delivery by biodegradable polymers of chemotherapy for recurrent gliomas. The Polymer-brain Tumor Treatment GroupLancet 345: 1008-1012, 1995
10. Valtonen S, Timonen U, Toivanen P, Kalimo H, Kivipelto L, Heiskanen O, Unsgaard G, Kuurne T Interstitial chemotherapy with carmustine-loaded polymers for high-grade gliomas: A randomized double-blind studyNeurosurgery 41: 44-48, 1997; discussion 48-49
11. Menei P, Benoit JP, Boisdron-Celle M, Fournier D, Mercier P, Guy G Drug targeting into the central nervous system by stereotactic implantation of biodegradable microspheresNeurosurgery 34: 1058-1064, 1994 discussion 1064
12. Joki T, Machluf M, Atala A, Zhu J, Seyfried NT, Dunn IF, Abe T, Carroll RS, Black PM Continuous release of endostatin from microencapsulated engineered cells for tumor therapy Nat Biotechnol 19: 35-39, 2001
13. Westphal M, Hilt DC, Bortey E, Delavault P, Olivares R, Warnke PC, Whittle IR, Jaaskelainen J, Ram Z A phase 3 trial of local chemotherapy with biodegradable carmustine (BCNU) wafers (Gliadel wafers) in patients with primary malignant glioma Neuro-oncology 5: 79-88, 2003
14. McGovern PC, Lautenbach E, Brennan PJ, Lustig RA, Fishman NO Risk factors for postcraniotomy surgical site infection after 1,3-bis (2-chloroethyl)-1-nitrosourea (Gliadel) wafer placement Clin Infect Dis 36: 759-765, 2003
15. Weber EL, Goebel EA Cerebral edema associated with Gliadel wafers: Two case studies Neuro-oncology 7: 84-89, 2005
16. Yoshioka H, Mikami M, Mori Y, Tsuchida E A synthetic hydrogel with thermoreversible gelation.: Preparation and rhological properties J Macromol Sci A31: 113-120, 1994
17. Yoshioka H, Mikami M, Mori Y, Tsuchida E A synthetic hydrogel with thermoreversible gelation.?: Effect of added salts J Macromol Sci A31: 1201-1205, 1994
18. Yoshioka H, Mikami M, Mori Y, Tsuchida E A synthetic hydrogel with thermoreversible gelation. III: An NMR study of the sol-gel transition Polym Adv Tech 5: 122-127, 1994
19. Yoshioka H, Mori Y, Tsukikawa S, Kubota S Thermoreversible gelation on heating and on cooling aqueous gelatin-poly(N -isopropylacrylamide) conjugate Polym Adv Tech 9: 155-158, 1998
20. Tsukikawa S, Matsuoka H, Kurahashi Y, Konno Y, Satoh K, Satoh R, Isogai A, Kimura K, Watanabe Y, Nakano S, Hayashi J, Kubota S A new method to prepare multicellular spheroids in cancer cell lines using a thermo-reversible gelation polymer Artif Organs 27: 598-604, 2003
21. Yoshioka H, Mori Y, Shimizu M Separation and recovery of DNA fragments by electrophoresis through a thermoreversible hydrogel composed of poly(ethylene oxide) and poly(propylene oxide)Anal Biochem 323: 218-223, 2003
22. Hishikawa K, Miura S, Marumo T, Yoshioka H, Mori Y, Takato T, Fujita T Gene expression profile of human mesenchymal stem cells during osteogenesis in three-dimensional thermoreversible gelation polymerBiochem Biophys Res Commun 317: 1103-1107, 2004
23. Shimizu S, Yamazaki M, Kubota S, Ozasa T, Moriya H, Kobayashi K, Mikami M, Mori Y, Yamaguchi S In vitro studies on a new method for islet microencapsulation using a thermoreversible gelation polymer, N -isopropylacrylamide- based copolymer Artif Organs 20: 1232-1237, 1996
24. Baker R. In: Controlled Release of Bioactive Materials, Academic, New York, 1980, pp 13-14
25. Lee EKL, Lonsdale HK, Baker RW, Drioli E, Bresnahan PA Transport of steroids in poly(etheruethane) and poly(ethylene vinyl acetate) membranesJ Membr Sci 24: 125-143, 1985
26. Imaizumi M, Kondo T, Taguchi T, Hattori T, Abe O, Kitano M, Wakui A A standardized method of using nude mice for the in vivo screening of antitumor drugs for human tumorsSurg Today 23: 412-419, 1993
27. Brem H, Tamargo RJ, Olivi A, Pinn M, Weingart JD, Wharam M, Epstein JI Biodegradable polymers for controlled delivery of chemotherapy with and without radiation therapy in the monkey brainJ Neurosurg 80: 283-290, 1994
28. Ram Z, Culver KW, Oshiro EM, Viola JJ, DeVroom HL, Otto E, Long Z, Chiang Y, McGarrity GJ, Muul LM, Katz D, Blaese RM, Oldfield EH Therapy of malignant brain tumors by intratumoral implantation of retroviral vector-producing cells Nat Med 3: 1354-1361, 1997
29. Westphal M, Giese A Local control of gliomas: The next best step - a good step? Front Radiat Ther Oncol 33: 214-226, 1999
30. Harbaugh RE, Saunders RL, Reeder RF Use of implantable pumps for central nervous system drug infusions to treat neurological diseaseNeurosurgery 23: 693-698, 1988
31. Cater SK, Anitha RAdriamycin-thoughs for the futureCancer Chemother Res 63: 1877-1883, 1975
32. Young C, Ozols RF, Myers CE The anthracycline antineoplastic drugs N Engl J Med 305: 139-153, 1981
33. Rahman A, Joher A, Neefe JR Immunotoxicity of multiple dosing regimens of free doxorubicin and doxorubicin entrapped in cardiolipin liposomesBr J Cancer 54: 401-408, 1986
34. Bally MB, Nayar R, Masin D, Cullis PR, Mayer LD Studies on the myelosuppressive activity of doxorubicin entrapped in liposomesCancer Chemother Pharmacol 27: 13-19, 1990